The #POIESISTrial is seeking participants aged 18+ for a large global Phase 3 study in patients with #myelofibrosis who have never been treated with a JAK inhibitor. Want to know more? Visit us today at poiesis-trial.com

Enjoyed speaking at MPN Asia yesterday, albeit virtually from here in Houston!Much thanks to the organizers and moderator Katsuto Takenaka for bearing with the technical challenges at my end! This is such a fantastic meeting. #MPNSM

Prithviraj Bose from MD Anderson Cancer Center discusses how recent advancements in molecular diagnostics, targeted therapies, and individualized treatment approaches give them greatest optimism for patients with polycythemia vera. hubs.ly/Q03dFVyN0

Looking forward to a fun and stimulating 2 days of MPN and MDS education and discussion with friends and colleagues! ⁦Rami komrokji⁩ ⁦MD Education⁩ #MPNSM #MDSSM new.md-education.com/mpn-mds-us-25

👉👉👉MD Education MPN, CHIP/CCUS & MDS faculty all coming together to discuss new ideas ! #MPNSM #leusm ||| 🙌 💡 Ruben A. Mesa, MD Naveen Pemmaraju, MD | Heme Reports MPNCo&D Congress Aditi Pemmaraju, J.D. Sanam Loghavi, MD صنم لغوی 🔬🧬 Hannah Goulart Zhuoer (Zoey) Xie, MD, MSCR Yazan Madanat, MD Mike Fradley, MD Elf Lab 🇺🇦🏳️‍🌈🏳️‍⚧️⚧️👊🏾👊🏽🌈🟧

Great to see this out and hope it will serve as a comprehensive contemporary reference on PV. Thanks Claire Harrison for the opportunity to contribute and for seeing this through to the finish! ⁦J.J. Kiladjian⁩ ⁦Ruben A. Mesa, MD⁩ ⁦#MPNSM nature.com/articles/s4157…

In this #HOPLive roundtable discussion, Drs. Prithviraj Bose (MD Anderson Cancer Center), Naseema Gangat (Mayo Clinic), Pankit Vachhani (UAB O'Neal Comprehensive Cancer Center), and Idoroenyi Amanam, MD (City of Hope) explore the latest advancements in the molecular biology of #myelofibrosis. ➡️ buff.ly/tJbSDPb

In the second #myelofibrosis roundtable segment from #HOPLive, Prithviraj Bose, Naseema Gangat, Pankit Vachhani, and Idoroenyi Amanam, MD dive into the current treatment landscape and ongoing clinical research shaping the future of care. 📺 Watch now! buff.ly/aW3Mfqe

In the next installment of the #myelofibrosis roundtable rom #HOPLive, the panel discusses patient-centered approaches in today’s treatment paradigm. Prithviraj Bose Naseema Gangat Pankit Vachhani Idoroenyi Amanam, MD 📺 Watch now! buff.ly/EYUcVuV

Happy to share our latest review on the latest JAKi (granted not so new any more) to be approved for MF! Great job Ruchi Desai and thanks ⁦Pankit Vachhani⁩ for the creative title! #MPNSM ⁦ tandfonline.com/doi/full/10.10…

A very proud mentor moment of Andrew Kuykendall MD for amazing presentation at ASCO plenary session Moffitt Cancer Center

Excellent oral abstract session on innovative treatments for #MPNSM at #EHA25! Robust early data on elritercept for anemia of MF, nuvisertib for MF post JAKi and ropeg for prefibrotic and early overt MF. Excited to see what the future brings for these promising agents!

Sustained benefits of rux+pelabresib over rux+placebo in 1L MF at week 72 in the phase 3 MANIFEST2 study. Especially good to see the difference between the arms in rates of leukemic transformation narrowing over time. #EHA25 #MPNSM

Important practice relevant data on anemia supportive agents used in combination with rux in the large JUMP trial nicely presented by Pankit Vachhani at #EHA25. And that’s not even considering luspatercept. #MPNSM

Wrapping up a tour of the Sintra Pena Palace on a hot day here in Lisbon! ⁦Abdulraheem Yacoub⁩ ⁦Marina Kremyanskaya, MD, PhD⁩ ⁦Prithviraj Bose⁩ #MPNSM #iwMDSMPN2025

🙌 ICYMI: in this roundtable discussion, Prithviraj Bose, Naseema Gangat, Pankit Vachhani, and Idoroenyi Amanam, MD explore patient-centered approaches within the current treatment paradigm for #myelofibrosis. ➡️ buff.ly/f2W2A3k

What an honor for MD Anderson Cancer Center to again be #1 in the nation in cancer care, according to @USNews. I am deeply appreciative of everyone in our MD Anderson community: each of you played a role in this extraordinary accomplishment as we work together to #EndCancer.

🚨We've just published a new podcast episode! This episode compiles some of our highlights from #iwMPN25, covering novel frontline approaches to #Myelofibrosis management, cardiovascular health in MPNs & the application of AI in the space. 🎧 Listen now 👉

Now that #SOHO25 is completed, tune in to a few #HealthcareUnfiltered EXPRESS quick episodes on emerging therapies and data in various heme cancers. This week, Prithviraj Bose of MD Anderson Cancer Center joins me to share what to watch for in MPNs. Check it out coming later this week.

All 4 of the FDA-approved JAK inhibitors for myelofibrosis have unique toxicity profiles that all patients and physicians must be aware of, said Prithviraj Bose, MD. hubs.li/Q03JrkMW0 #myelofibrosis #SOHO2025 | Prithviraj Bose MD Anderson Cancer Center